About: ECMO管理を要した重症COVID–19市中肺炎に対して腹臥位療法やステロイドの全身投与により軽快した2例(Two cases of severe coronavirus disease 2019 community–acquired pneumonia successfully treated with extracorporeal membrane oxygenation and prone positioning and systemic corticosteroid therapy)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: ECMO管理を要した重症COVID–19市中肺炎に対して腹臥位療法やステロイドの全身投与により軽快した2例(Two cases of severe coronavirus disease 2019 community–acquired pneumonia successfully treated with extracorporeal membrane oxygenation and prone positioning and systemic corticosteroid therapy) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	ECMO管理を要した重症COVID–19市中肺炎に対して腹臥位療法やステロイドの全身投与により軽快した2例(Two cases of severe coronavirus disease 2019 community–acquired pneumonia successfully treated with extracorporeal membrane oxygenation and prone positioning and systemic corticosteroid therapy)
Creator	Egawa, Yuko Hayakawa, Katsura Kamiyama, Jiro Kiyota, Kazuya Sakamoto, Saki Taguchi, Shigemasa Yasaka, Koichi
Source	PMC
abstract	The first case was that of a 58–year–old man diagnosed with coronavirus disease 2019 (COVID–19) pneumonia after 7 days of fever. Favipiravir was administered on admission; however, the patient’s respiratory status worsened with high fever. On day 2 of admission, after tracheal intubation, maintaining oxygenation was difficult after initiating mechanical ventilation, and extracorporeal membrane oxygenation (ECMO) was initiated. On day 5, prone positioning and corticosteroid therapy were started. The patient was weaned from ECMO on day 9 and from ventilator support on day 11. On day 27, he was discharged ambulatory. The second case was that of a 44–year–old man who complained of dyspnea after 12 days of fever. After tracheal intubation, he was diagnosed with COVID–19 pneumonia. Favipiravir was administered on admission; nevertheless, the patient’s respiratory status worsened gradually with high fever. On day 4 of admission, ECMO and corticosteroid therapy were initiated. On day 5, prone positioning was started. The patient was weaned from ECMO on day 12 and from ventilator support on day 15. On day 30, he was discharged ambulatory. The aggravation of COVID–19 pneumonia may be associated with excessive inflammation; therefore, some patients were effectively treated with corticosteroid therapy.
has issue date	2020-08-06(xsd:dateTime)
bibo:doi	10.1002/jja2.12488
has license	no-cc
sha1sum (hex)	8ab1765c6c671b13f8b356a821eaae72df7df69c
schema:url	https://doi.org/10.1002/jja2.12488
resource representing a document's title	ECMO管理を要した重症COVID–19市中肺炎に対して腹臥位療法やステロイドの全身投与により軽快した2例(Two cases of severe coronavirus disease 2019 community–acquired pneumonia successfully treated with extracorporeal membrane oxygenation and prone positioning and systemic corticosteroid therapy)
has PubMed Central identifier	PMC7436470
resource representing a document's body	covid:8ab1765c6c671b13f8b356a821eaae72df7df69c#body_text
is schema:about of	named entity 'extracorporeal' named entity 'membrane oxygenation' named entity 'extracorporeal membrane oxygenation' named entity 'high fever' named entity 'ECMO' named entity 'corticosteroid therapy' named entity 'corticosteroid therapy' named entity 'ECMO' named entity 'tracheal intubation' named entity 'COVID' named entity 'ventilator support' named entity 'ventilator support' named entity 'inflammation' named entity 'pneumonia' named entity 'pneumonia' named entity 'Favipiravir' named entity 'high fever' named entity 'fever' named entity 'COVID' named entity 'dyspnea' named entity 'weaned' named entity 'weaned' named entity 'Favipiravir' named entity 'corticosteroid therapy' named entity 'fever' named entity 'ECMO' named entity 'coronavirus disease 2019' named entity 'pneumonia' named entity 'tracheal intubation' named entity 'mechanical ventilation' named entity 'ECMO' named entity 'COVID-19' named entity 'ECMO' named entity 'coronavirus disease 2019' named entity 'extracorporeal membrane oxygenation' named entity 'extracorporeal membrane oxygenation' named entity 'corticosteroid therapy' named entity 'ECMO' named entity 'COVID-19' named entity 'community-acquired pneumonia' named entity 'successfully treated' named entity 'ECMO' named entity 'COVID-19' named entity 'ECMO' named entity 'day' named entity 'ECMO' named entity 'coronavirus disease 2019' named entity 'ECMO' named entity 'COVID-19' named entity 'cases' named entity 'ECMO' named entity 'COVID-19' named entity 'COVID-19' named entity 'corticosteroid' named entity 'ECMO' named entity 'day' named entity 'membrane oxygenation' named entity 'ECMO' named entity 'extracorporeal' named entity 'Two' named entity 'severe' named entity 'community-acquired pneumonia'
is part of of	ECMO管理を要した重症COVID–19市中肺炎に対して腹臥位療法やステロイドの全身投与により軽快した2例(Two cases of severe coronavirus disease 2019 community–acquired pneumonia successfully treated with extracorporeal membrane oxygenation and prone positioning and systemic corticosteroid therapy) covid:8ab1765c6c671b13f8b356a821eaae72df7df69c#body_text The first case was that of a 58–year–old man diagnosed with coronavirus disease 2019 (COVID–19) pneumonia after 7 days of fever. Favipiravir was administered on admission; however, the patient’s respiratory status worsened with high fever. On day 2 of admission, after tracheal intubation, maintaining oxygenation was difficult after initiating mechanical ventilation, and extracorporeal membrane oxygenation (ECMO) was initiated. On day 5, prone positioning and corticosteroid therapy were started. The patient was weaned from ECMO on day 9 and from ventilator support on day 11. On day 27, he was discharged ambulatory. The second case was that of a 44–year–old man who complained of dyspnea after 12 days of fever. After tracheal intubation, he was diagnosed with COVID–19 pneumonia. Favipiravir was administered on admission; nevertheless, the patient’s respiratory status worsened gradually with high fever. On day 4 of admission, ECMO and corticosteroid therapy were initiated. On day 5, prone positioning was started. The patient was weaned from ECMO on day 12 and from ventilator support on day 15. On day 30, he was discharged ambulatory. The aggravation of COVID–19 pneumonia may be associated with excessive inflammation; therefore, some patients were effectively treated with corticosteroid therapy.

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software